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VACCINATION AGAINST TUBERCULOSIS WITH
ULTRASONIC-VIBRATED TUBERCLE BACILLI
JOSEPH PAUL TRUANT, Ph.D.*

Numerous attempts have been made by many investigators'"^ to induce protective
immunity against tuberculosis by a variety of vaccination programs. Early studies were
initiated shortly after the discovery of the tubercle bacidi by Koch in 1882. Since
this time, the majority of experiments have been conducted on the basis of four
types of vaccines as fodows:

|

1. Preparations of tubercle bacidi killed by a variety of physical and chemical
methods.
2. small numbers of living, virulent tubercle bacilli.
3. species of Mycobacterium isolated from nonmammalian sources.
4. avirulent organisms of originally virulent strains which were attenuated by
various methods.
Immunization with a variety of living, attenuated strains and with several nonliving preparations has been shown to produce a significant degree of enhanced resistance for both domestic and laboratory animals as well as man. However, only
one of these has been used to any extent in the latter. This vaccine is prepared from
an attenuated bovine culture and is known as BCG (Bacide Calmette-Guerin).
Vaccination with BCG preparations has stimulated numerous controversies during
the past four decades. The general desirabdity of this approach to the tuberculosis
problem has been evaluated on the basis of efficacy, safety etc. Midions of people have
been vaccinated with BCG vaccines during recent years but there is stdl no absolute
agreement on this subject. As a result, there are persuasive arguments for and against
the use of these vaccines in the current journals.
The literaure''"' contains numerous reports on the advantages and disadvantages
of BCG vaccines. The data on this subject can be summarized as follows:
1. The vaccines give some protection in those individuals who are directly exposed to tuberculosis infection either at home or at work.
2. a reduction of tuberculosis occurs in many of the general populations wherein
the individuals have low living standards and high tuberculosis rates.
3. the extent and duration of protection, as well as the contribution to the control
of tuberculosis in areas where tuberculosis services are good, should still be
regarded as problematical.
Ultrasonic-vibrations were used by Kress' in 1948 to kdl a suspension of virulent
human tubercle bacilli. A few guinea pigs were vaccinated subcutaneously with the
killed suspension and challenged six weeks later by the intranasal introduction of
*Department of Laboratories.
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virulent tubercle bacilli. The animals failed to develop tuberculosis but it should be
emphasized that the experiment lacked adequate controls. Therefore, this study cannot be considered to have much significance.
Our objective was to investigate the immunizing properties of ultrasonic-treated
tubercle bacdli and to compare these preparations with BCG vaccines. We were
especially interested in this approach since chemically and heat-treated whole-cell
vaccines have been studied for years with questionable promise. It was decided to use
several strains of tubercle bacilli which were both virulent and avirulent for man.
MATERIALS A N D METHODS
The vaccines reported in this study were prepared using Mycobacterium tuherculo.sis
varieties identified as H37, H37Rv, H37Ra as wed as a chromogenic strain of acidfast bacillus. Suspensions of each organism were vibrated separately at 10,000 oscillations* per minute for periods of 5-15 minutes. Since viable organisms were found in all
treated preparations it was decided to treat all preparations with 0.35 per cent tricresol
in order to inactivate the small number of living tubercle bacilli and have it act as
a preservative at the same time. Multiple subcultures for sterility testing were examined
for 150 days because d has been our experience that 80-120 days was not sufficient.
A total of eleven vaccines (see Table I ) were prepared using the above methods in
an attempt to obtain preparations which might be effective immunizing agents.
Table I
ULTRASONIC TREATMENT OF TUBERCLE BACILLI
Vaccine #

Organism

1

H37Rv

5

1108

2

H37Rv

10

1198

3

H37Rv

10

1007

4

H37Rv

15

1108

5

H37Rv

15 *supernatant

6

H37

5

7

H37

10

697

X

H37

15

617

9

H37

15 *supernatant

10

H37Ra

15

11

Chromogen

15

Ultrasonic Vibrations
in Minutes

mg of Nitrogen
per 100 ml of specimen

33
78;)

32.8
7i.8
61.5

*The supernatant of each of the 15 minute treated H37Rv (#5) and H37 (#9) were also tested
for their immunizing properties.

This report deals with two series of experiments. The first consisted of an evaluation
of the evelen vaccines using a group of 10 guinea pigs for each preparation. The second
series consisted of two udrasonic-treated antigens as well as BCG. Guinea pigs weighing
*A sonic oscillator, manufactured by Raytheon Manufacturitig Company, Waltham, Mass., was used.
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approximately 300 grams were used throughout these studies. For randomization, the
cages in any one experimental group were distributed so that one cage would be
found in the first quarter of the total number, a second cage in the second quarter of
the total and so on. Tuberculin sensitivity testing of control and vaccinated animals was
conducted using Eli Lily's tuberculin preparation. The tuberculin tests were performed
28-30 days after the initial vaccination procedure together with tests of the unvaccinated controls. The results were read at 24 and 48 hours, a positive reaction being
5 mm. or more in minimum diameter. In some instances, reactions were strong with a
blanched, later necrotic, center.
The immunization doses were administered subcutaneously in the inguinal region.
Each animal received five injections at 7 day intervals with the following volumes:
0.5, 1.0, 1.5, 2.0 and 2.0 mis. A comparable group of animals recieved corresponding
volumes of saline. A supply of freeze-dried vaccine was obtained from Sol Rosenthal
of the Research Foundation, Chicago. It was administered by the "Multiple Puncture
Disc Technique" as outlined in the directions of the supplier. Three weeks after the
last immunizing dose the animals were challenged with 1 ml. of a virulent strain of
Mycobacterium tuberculosis var. hominis (approximately 0.1 mg., semi-dry weight,
of a ten day culture) subcutaneously in the inguinal area.
The experiments were evaluated in two ways: (1) the extent of gross and histological tuberculous infection (Table 2, 3) as measured by an adaptation of the
Feldman Index'. Observations were as detailed as possible on all major organs — lungs,
liver, spleen, inguinal and retroperitoneal nodes. Acid-fast smears and cultures were
also performed on the specimens. (2) by the average survival time for each group of
animals.
Table 11*
Key Table for Evaluating Histologically the Extent and Character of the Tuberculous Lesions in
Experimentally Infected Guinea Pigs. Assign the Highest Number Corresponding to the Description
of the Lesion in Each Tissue.
Extent and Character of Lesions

Progressive lesions present
Extensive involvement
Moderate
Slight
Nonprogressive lesions only
Fibrosis, hard tubercles
Fibrosis or calcification only

Liver

If Lung is Negative
Site of
Examine
Inoculation
and Contiguous Tracheo-bronchial
Lymph Nodes
Lymph Nodes

Spleen

Lung

35
20
10

30
20
10

25
20
10

10
10
10

10
10
10

3
1

3
1

2
I

1
1

1
1

35

. 30

25

10

10
(If lung is negative)

If only inactive lesions, maximal
values less than 10
(If lung is negative)
*This table was copied from Feldman's paper (9).
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Table I I I
Method for Evaluating by Gross Appearance the Extent and Character of Tuberculous Lesions in
Experimentally Infected Guinea Pigs*
Extent of Involvement
in Tissues Examined
Extensive 3-|- to 4-|Moderate 2-|Slight
HMaximum Values
100 Total

Spleen
35
20
10
35

Lung
30
20
10
30

Site of
Inoculation
10
10
10
10

Liver
25
20
10
25

Tracheal bronchial
Nodes with
Negative Lung
10
10
10
10
(If lung is negative)

*Shght Modification of Feldman's procedure'.

Result: The purpose of the first series of experiments was to ascertain whether
there was any evidence that the ultrasonic-treated organisms possessed potential antigenic value. The animals in the eleven experimental and one control group — No. 12
— (Table 4) were autopsied at the time of death and the average survival rates are
summarized in Table 4. The data show that antigens #7 and #8 increased the survival
time to a greater extent than the other antigens. Statistical evaluation of the results
obtained on the animals in each group showed that the probabiliy values for vaccine
#7 and *8 were significant.
Table I V
Identification of Vaccines

Average number
of days after
challenging

1
6X

2
69

3
62

H37Ra Chromo- Control
genie

H37

H37RV
4
81

5

6

36 85

9

10

11

12

128 108 40

K6

77

4.«

7

8

The apparent increase in resistance to tuberculosis produced by antigens #7 and
*8 in the first series of experiments led us to compare their immunizing properties
with those of BCG as well as to confirm the results of the first series of experiments.
Thirty animals were used in each group of the second experimental series including a
similar number in two controls (one of which received saline and the other no injections).
The guinea pigs were tested with tuberculin after the 5 immunization doses had been
given at weekly intervals. Slightly more than fifty per cent of the animals showed
strongly positive tuberculin tests. The other fifty per cent were either weekly reactive
or negative.
The results of the survival times for the animals of the second experimental
series are listed in Table 5. The data serve to emphasize that BCG produced much
greater resistance against tuberculosis than did vaccine preparations #7 and #8. Thus,
there is a striking degree of protection (Table 5) exhibited by BCG vaccine. This
preparation produced a survival time of greater than 107 days as compared to the
41, 39, 51 days for vaccines #7, 8 and the saline controls respectively. The control
group which did not receive a challenge dose (Table 5) was included to evaluate
intercurrent infections in the animal colony. The animals which survived in this
441
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latter group were sacrificed 200 days after the date of challenge and showed an
average survival value of greater than 161 days.
Table V
Results of Experimental Series #2
Vaccine

Description

#7
#8
BCG
Controls

H37 10 min.
H37 15 min.
Research Foundation
Saline
—Animals challenged
—Saline only
—No chaUenging dose

Controls

Per cent of animals
Tuberculin Positive
after Immunization
55%
66%
59%
0%
0%

Average Survival
Period in Days
41
39
>107
51
>161

All animals which had received a challenging dose and survived for a two week
period thus avoiding intercurrent infection, eventually showed moderate to extensive
tuberculosis. This conclusion has been based on the results obtained wdh the Feldman
method' for evaluating both the gross and histological tuberculosis (Tables 2 and 3)
changes in the infected guinea pigs.
Intercurrent infections were usually high in all groups. Therefore, it was always
necessary to quarantine the animals for several weeks before beginning the immunizing
dose. To avoid errors due to intercurrent disease it was imperative that all animals
be autopsied rather than to depend on death and survival rates only.
DISCUSSION
The results of the first experimental series provides further evidence (Table 4)
that a degree of enhanced resistance to tuberculosis can be produced not only by living
but also by killed tubercle bacilli. Electron micrographs of the ultrasonic treated
suspensions showed both intact and fragmented cells. 'Vaccines number 5 and 9 which
consisted of supernatant from H37 preparations were immunogenically inactive. Thus,
one may conclude that the sediments were capable of enhancing resistance to tuberculosis to a greater extent than the supernatant materials under test.
An important but controversial issue in tuberculosis is the role of tuberculin skin
hypersensitivity in protective immunity. The experiments in which the vaccines were
capable of increasing the resistance of the animals to tuberculosis often did so without making the animals skin-hypersensitive to tuberculin. The reverse was also common
— the tuberculin positive animals frequently showed little or no resistance to the
challenging dose of tubercle bacdli. Emphasis should be placed on the fact that the
absence of skin hypersensitivity to an antigen does not always indicate total absence
of systemic hypersensitivity. Furthermore, tuberculin preparations which were employed to test for sensitivity consisted of the usual heated preparations, and the absence
of a reaction to these does not necessarily mean that the animal would not be
sensitive to unhealed tuberculoproteins. Thus, the independence of tuberculin skin
hvpersensitivity and acquired resistance to tuberculosis should be considered in discussing this complex subject.
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The work of Weiss' as well as this report support the contentions of other investigators that the development of acquired immunity to tuberculosis does not require
infection with living tubercle bacidi. Immunity to tuberculosis can be bestowed by
either components or whole nonliving ceds which at times may also lack skin-sensdizing
properties.
An attempt was made with the first series of our experiments to determine the
extent of antigenic activity of the eleven vaccines. Having demonstrated that vaccines
* 7 and 8 were statistically significant when compared with the controls, the second
series was designed to answer two questions:
1. Would the vaccines retain their antigenic activity on storage for a one
year period?
2. How effective would the preparations be when compared wdh BCG?
A comparison of the survival periods (Table 6) shows vaccines #7 and 8 to be of
extremely short durations. In fact, the figures are smaller than those shown for the
control group. This might indicate that toxic substances as wed as other unknown
factors may have contributed to a shortening of the survival time. The wide differences
between the results of the first and second series may possibly be due to loss of potency
during the storage period.
If one examines the survival period for the BCG group (107 days) in series
number 2 (Table 6) and compares this wdh the results of series number 1 (128 and
108 days), the data show that the nonliving vaccines were at least as effective against
tuberculosis as the living one (BCG). It is evident from a perusal of the dterature
that the majority of experimental data in which nonliving antituberculosis vaccines
(ie. phenol killed, methanol extracts etc.) were tested that such preparations possess
approximately equal immunogenicity as living, attenuated ones. Although a number
of technical problems — variation in dosage, route of administration, vaccinationchallenge interval, method of evaluating the data, etc. — require further attention.
There is sufficient evidence that killed tubercle bacilli and some of their extracts
definitely have immunizing properties".
Table V I
Survival Period in Days for the Two Series of Experiments
Series I

Series 2

Vaccine #7

128

41

Vaccine #8

108

39

48

51

not done

107

Control
Saline -h Challenging
dose
BCG

Safety of vaccination is another very important consideration since one wants
to prevent, not initiate progressive disease. It should be understood that safety, as it
refers to any pathologic process due to vaccination, is not always assumed. Therefore,
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it is of primary importance that the toxigenic properties of nonliving vaccines be
investigated.
It is possible that there may be a decrease in efficacy with corresponding increases
in dosages" even to levels still below that at which physical symptoms of illness
appear. This is an indication that a threshold area of toxicogenicity exists in evaluating
"tuberculosis vaccines".
Other arguments in favour of killed vaccines have been previously reviewed at
length by Weiss". The results of the first experiment in this report are an indication
that ultrasonic-treated bacilli have immunizing properties. The increase in resistance
demonstrated by the prolonged survival time of the animals suggests that further
studies be done. Furthermore, the data obtained in the second experiment show BCG
to be a superior vaccine. One cannot discount the fact that vaccines #7 and 8 showed
comparable effectiveness in experimental series number one.
SUMMARY A N D CONCLUSION
Two of eleven vaccines prepared by ultrasonic vibration of four strains of
Mycobacterium were found to stimulate increased resistance to tuberculosis when
compared to the saline control group which was challenged with comparable inoculum.
The data were statistically significant .The other nine preparations did not show protective activity to the same extent.
The two vaccines were not as effective after storing at 4°C for a one year period.
In fact the 'stored' vaccines appeared to cause a toxic effect. Parallel experiments
showed that BCG prolonged the survival time to a much greater degree than the two
'stored' vaccines.
A review of the data suggests that the ultrasonic-treated antigens (vaccine #7, 8)
in the first series of experiments were equally as potent as BCG in the second series.
For this reason as well as the fact that the results of the first experimental series were
statistically significant, further studies should be undertaken using freshly prepared
ultrasonic treated vaccines and BCG.
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